Abstract
Platelets play an important role in cardiovascular thrombosis as well as in many other pathological conditions such as inflammation, atherosclerosis and cancer. While multi-target strategies to treat complex diseases are gaining considerable attention, current development of antiplatelet therapies is mostly oriented towards several single targets, arising from our present understanding of the regulation of platelet activation. Limited efforts to develop multi-target agents or multidrug therapies are mostly due to a lack of a systematic basis to define target combinations with synergistic effects. Here we discuss the perspective to use high content phenotypic screening of in vitro models as a potential source for inference of synergetic multi-target strategies to control platelet activation.
Keywords: Antiplatelet therapies, CASP3, COX1, high content screening, KLF5, multi-target therapies, NPC1, PKM, polypharmacology, platelets, SENP6, TNFSF10, SENP.
Mini-Reviews in Medicinal Chemistry
Title:Perspective on Multi-Target Antiplatelet Therapies: High Content Phenotypic Screening as an Unbiased Source of Novel Polypharmacological Strategies
Volume: 15 Issue: 8
Author(s): Vivien Landre, Ivano Amelio, Nick A. Barlev, Richard A. Knight, Andrey Lisitsa, Gerry Melino and Alexey V. Antonov
Affiliation:
Keywords: Antiplatelet therapies, CASP3, COX1, high content screening, KLF5, multi-target therapies, NPC1, PKM, polypharmacology, platelets, SENP6, TNFSF10, SENP.
Abstract: Platelets play an important role in cardiovascular thrombosis as well as in many other pathological conditions such as inflammation, atherosclerosis and cancer. While multi-target strategies to treat complex diseases are gaining considerable attention, current development of antiplatelet therapies is mostly oriented towards several single targets, arising from our present understanding of the regulation of platelet activation. Limited efforts to develop multi-target agents or multidrug therapies are mostly due to a lack of a systematic basis to define target combinations with synergistic effects. Here we discuss the perspective to use high content phenotypic screening of in vitro models as a potential source for inference of synergetic multi-target strategies to control platelet activation.
Export Options
About this article
Cite this article as:
Landre Vivien, Amelio Ivano, Barlev A. Nick, Knight A. Richard, Lisitsa Andrey, Melino Gerry and Antonov V. Alexey, Perspective on Multi-Target Antiplatelet Therapies: High Content Phenotypic Screening as an Unbiased Source of Novel Polypharmacological Strategies, Mini-Reviews in Medicinal Chemistry 2015; 15 (8) . https://dx.doi.org/10.2174/1389557515666150219124018
DOI https://dx.doi.org/10.2174/1389557515666150219124018 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?)
Current Pharmacogenomics and Personalized Medicine Gene Expression Profiling of Epithelial Ovarian Cancer
Current Genomics Advances of Paclitaxel Formulations Based on Nanosystem Delivery Technology
Mini-Reviews in Medicinal Chemistry Induction of GST and Related Events by Dietary Phytochemicals: Sources, Chemistry, and Possible Contribution to Chemoprevention
Current Topics in Medicinal Chemistry Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Graphical Abstracts
Current Nanoscience Cancer-Homing Toxins
Current Pharmaceutical Design Lactoferrin Suppresses Decreased Locomotor Activities by Improving Dopamine and Serotonin Release in the Amygdala of Ovariectomized Rats
Current Molecular Pharmacology Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry Diverse Models for the Prediction of Dual mTOR and PI3Kα Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines
Letters in Drug Design & Discovery Immunophilin Chaperones in Steroid Receptor Signalling
Current Topics in Medicinal Chemistry Effects of Peptidic Antagonists of Grb2-SH2 on Human Breast Cancer Cells
Protein & Peptide Letters Flavonoids as Anticancer Agents: Recent Progress and State of the Art?
Current Organic Chemistry Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia
Infectious Disorders - Drug Targets Erratum
Current Proteomics Anticancer Drugs Discovery and Development from Marine Organisms
Current Topics in Medicinal Chemistry Cyclopeptides from Marine Organisms
Mini-Reviews in Organic Chemistry Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design